Managing Constipation in Palliative Care: Nursing Strategies
This paper examines nursing strategies for managing constipation in palliative care settings, drawing on clinical literature to compare pharmacological and non-pharmacological interventions. It reviews the risks associated with opioids and various laxative types, including lubricant, bulk, surface, and osmotic formulations, while also evaluating suppositories and newer agents such as Relistor. Non-pharmacological approaches discussed include increased fluid intake, dietary modifications, exercise, bowel habit training, biofeedback, and fecal management systems. The paper concludes that no single intervention is universally superior and that nurses must be well informed about available options to make individualized, knowledge-based decisions for each patient.
- Introduction: Frames the debate between pharmacological and non-pharmacological approaches
- Pharmacological Management of Constipation: Reviews risks of opioids and various laxative types
- Osmotic Laxatives and Suppositories: Discusses osmotic agents, suppositories, and Relistor
- Non-Pharmacological Interventions: Covers fluids, exercise, biofeedback, and bowel training
- Additional Non-Pharmacological Remedies: Dietary solutions and fecal management systems
- Conclusion: Calls for informed, individualized nursing decision-making
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper maintains a clear, parallel structure by organizing interventions into two distinct categories — pharmacological and non-pharmacological — making it easy for readers to compare approaches.
- It draws on multiple credible sources, including a PubMed clinical study, the Oxford Textbook of Palliative Nursing, and a Medscape review, lending authority to its clinical recommendations.
- Specific drug and treatment names are used throughout, grounding abstract nursing decisions in concrete clinical options.
Key academic technique demonstrated
The paper demonstrates synthesis of multiple clinical sources to support a nuanced, evidence-informed argument. Rather than advocating a single "best" intervention, it presents the trade-offs of each approach and defers final judgment to the nurse's clinical context — a sophisticated move that reflects real-world practice and avoids oversimplification.
Structure breakdown
The paper opens with a research question framing the central clinical debate. It then moves through pharmacological interventions in order of type (lubricant, bulk, surface, osmotic, suppositories, and specialty agents), followed by non-pharmacological strategies organized from primary priorities (fluids) to secondary options (diet, biofeedback, electric stimulation). A brief conclusion reinforces the need for nurses to remain current with the literature. The structure is functional and clinically oriented throughout.
Introduction
Which strategy is considered best when nurses must intervene with a patient suffering from constipation? A PubMed publication from the National Institutes of Health and the U.S. National Library of Medicine explains that there is some uncertainty within the healthcare field about the choice between managing constipation pharmacologically or through various other clinical programs in palliative care settings (Clemens et al., 2013). A section of the Oxford Textbook of Palliative Nursing dedicated to bowel management — authored by Caraccia Economou — similarly explains that there is no absolute rule as to which intervention is best (220).
Pharmacological Management of Constipation
The use of opioids is not always recommended for constipated patients, because opioids increase electrolyte and water absorption in both the small and large intestines, which can lead to dehydration and dry, hard stools (Economou, 221). Morphine is also not a recommended intervention because of the insensitivity it creates, which prevents the patient from sensing the need for a bowel movement.
In terms of pharmacological management, lubricant laxatives (mineral oil laxatives) can cause rectal leakage and are therefore not recommended. When patients use bulk laxatives without additional fluids, they risk bowel obstruction and hyperglycemia. The use of surface or detergent laxatives can help by increasing the absorption of water and fats, though they can lead to a reduction of electrolytes in both the small and large intestines (Economou, 221).
Osmotic Laxatives and Suppositories
Osmotic laxatives — such as Milk of Magnesia and Miralax — tend to increase fluid secretions in the small intestines and, to some degree, in the large intestines. They also lower ammonia levels, which is clinically beneficial. Suppositories are often rejected by some patients because they bring to mind an unpleasant concept, but they produce bowel movements quickly and are therefore a recommended form of pharmacological management (Economou, 222). When palliative patients do not respond to standard laxatives, Economou reports that Relistor has shown good success in addressing constipation.
Conclusion
Nurses need to be well informed about the most recent literature pertaining to the treatment of constipation in palliative situations. Whether pharmacological or non-pharmacological strategies are used, the decision should be made with thorough knowledge of the options available to each nurse in each unique healthcare environment.
Create your account
Always verify citation format against your institution’s current style guide requirements.